SI-BONE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
SI-BONE, INC. (SIBN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $10.80 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-08-04
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2026-03-31 was $5.73.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2023-03-31 was $21.36, a 47.72% increase year-over-year.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2025 was $19.87, a 66.00% increase from fiscal 2024.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2024 was $11.97, a 43.59% decline from fiscal 2023.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2023 was $21.22, a 41.00% increase from fiscal 2022.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2022 was $15.05, a 5.05% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.80 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | $5.73 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | $19.87 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $17.86 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | $17.81 10-Q · filed 2025-08-05 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | |||
| 2024-12-31 | $11.97 10-K · filed 2025-02-25 | |||
| 2024-09-30 | $11.97 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $18.47 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | $21.22 10-K · filed 2024-02-27 | |||
| 2023-09-30 | $21.22 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | $21.23 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | $21.36 10-Q · filed 2023-05-02 | |||
| 2022-12-31 | $15.05 10-K · filed 2024-02-27 | |||
| 2022-09-30 | $15.47 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | $12.36 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | $14.46 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $15.85 10-K · filed 2023-03-02 | |||
| 2021-09-30 | $15.78 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | $16.02 10-Q · filed 2021-08-04 | |||
| 2021-03-31 | $4.68 10-Q · filed 2021-05-04 | |||
| 2020-12-31 | $17.07 10-K · filed 2022-03-01 | |||
| 2020-09-30 | $17.21 10-Q · filed 2020-11-03 | |||
| 2020-06-30 | $14.75 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | $12.87 10-Q · filed 2020-05-05 | |||
| 2019-12-31 | $11.30 10-K · filed 2021-03-10 | |||
| 2019-09-30 | $9.36 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | $4.81 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |